Drug Search Results
More Filters [+]

Carbasalate calcium

Alternative Names: carbasalate calcium
Latest Update: 2024-12-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PA Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Croatia | Iceland | Ireland | Latvia | Netherlands | Poland | Portugal | Romania | Switzerland

Approved Indications: None

Known Adverse Events: None

Company: Leiden University Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carbasalate calcium

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Type 1 Diabetes|Arthritis, Rheumatoid|Hypertension

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ASPIRETENSION II

P3

Active, not recruiting

Hypertension

2012-08-18

2007-004354-90

P4

Active, not recruiting

Unknown

2008-03-03

ASPIRETENSION

P3

Active, not recruiting

Type 1 Diabetes|Arthritis, Rheumatoid|Hypertension

2006-11-02

Recent News Events